11-Feb-2025
How cancer cells trick the immune system by altering mitochondria
Okayama UniversityPeer-Reviewed Publication
Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment. However, cancer cells have developed immune evasion strategies, leading to poor treatment responses. Now, researchers from Japan have identified the transfer of mitochondria with mutated DNA from cancer cells to immune cells as a key mechanism of immune evasion and resistance to immunotherapy. Targeting this transfer could enhance the effectiveness of cancer immunotherapy.
- Journal
- Nature
- Funder
- Grants-in-Aid for Scientific Research, Challenging Exploratory Research, Grant-in-Aid for Research Fellow from the Japan Society for the Promotion of Science, Project for Cancer Research and Therapeutic Evolution, Practical Research for Innovative Cancer Control, Core Research for Evolutional Science and Technology, Practical Research Project for Rare/Intractable Diseases, Research Program for Hepatitis from the Japan Agency for Medical Research and Development, Fusion Oriented REsearch for disruptive Science and Technology, ACT-X from the Japan Science and Technology Agency, National Cancer Center Research and Development Fund, Chiba Prefecture Research Grant, Takeda Science Foundation, Naito Foundation, Mochida Memorial Foundation, MSD Life Science Foundation, GSK Japan foundation, Research Grant of the Princess Takamatsu Cancer Research Fund, Kowa Life Science Foundation, Kato Memorial Bioscience Foundation, Inamori Foundation, Astellas Foundation for Research on Metabolic Disorders, Suzuken Memorial Foundation, SGH Foundation, Sumitomo Foundation Grant for Basic Science Research Projects, Terumo Life Science Foundation, Chugai Foundation for Innovative Drug Discovery Science, The Ono Pharmaceutical Foundation for Oncology, Immunology, and Neurology, Kobayashi Foundation for Cancer Research, Taiju Life Social Welfare Foundation, 2023 Healthcare Innovation Research Grant established with donations from T. Togawa, Sequencing and bioinformatics analyses were performed on institutional computing resources that included hardware provided by NVIDIA